PREMERA SCOUT Trademark

Trademark Overview

On Wednesday, March 1, 2017, a trademark application was filed for PREMERA SCOUT with the United States Patent and Trademark Office. The USPTO has given the PREMERA SCOUT trademark a serial number of 87354955. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by Premera Blue Cross. The PREMERA SCOUT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing communication technology, namely, providing search platforms and voice enabled search platforms that enable users to request and obtain information in the medical, health, hospital, dental, prescription drug, pharmaceutical, wellness, fitness, exercise, diet, nutrition, health insurance, health care plan and health saving account areas; providing a website featuring technology that enables users to access, manage and process health, medical, hospital, pharmaceutical and prescription drug insurance applications, records, claims, benefits, accounts
premera scout

General Information

Serial Number87354955
Word MarkPREMERA SCOUT
Filing DateWednesday, March 1, 2017
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5874719
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 12, 2017

Trademark Statements

Goods and ServicesProviding communication technology, namely, providing search platforms and voice enabled search platforms that enable users to request and obtain information in the medical, health, hospital, dental, prescription drug, pharmaceutical, wellness, fitness, exercise, diet, nutrition, health insurance, health care plan and health saving account areas; providing a website featuring technology that enables users to access, manage and process health, medical, hospital, pharmaceutical and prescription drug insurance applications, records, claims, benefits, accounts

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, July 22, 2017
Primary Code042
First Use Anywhere DateFriday, February 2, 2018
First Use In Commerce DateFriday, February 2, 2018

Trademark Owner History

Party NamePremera Blue Cross
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMountlake Terrace, WA 98043
Party NamePremera Blue Cross
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeattle, WA 981110327
Party NamePremera Blue Cross
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeattle, WA 981110327

Trademark Events

Event DateEvent Description
Wednesday, May 31, 2017PRIORITY ACTION WRITTEN
Saturday, March 4, 2017NEW APPLICATION ENTERED
Wednesday, March 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 24, 2017ASSIGNED TO EXAMINER
Wednesday, May 31, 2017PRIORITY ACTION E-MAILED
Wednesday, May 31, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Friday, July 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 28, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, July 28, 2017EXAMINERS AMENDMENT E-MAILED
Friday, July 28, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 28, 2017EXAMINER'S AMENDMENT ENTERED
Saturday, July 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 23, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, September 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 7, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 30, 2018SOU TEAS EXTENSION RECEIVED
Monday, April 30, 2018SOU EXTENSION 1 FILED
Monday, April 30, 2018SOU EXTENSION 1 GRANTED
Wednesday, May 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 11, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, September 11, 2018USE AMENDMENT FILED
Monday, October 1, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 2, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 17, 2018SU - NON-FINAL ACTION - WRITTEN
Wednesday, October 17, 2018NON-FINAL ACTION E-MAILED
Wednesday, October 17, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 20, 2019ASSIGNED TO LIE
Tuesday, January 22, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 22, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 13, 2019SU - FINAL REFUSAL - WRITTEN
Wednesday, February 13, 2019FINAL REFUSAL E-MAILED
Wednesday, February 13, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 30, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, June 7, 2019ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Friday, June 7, 2019NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Monday, August 12, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, August 12, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 2, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 7, 2019ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Monday, August 12, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, November 14, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 14, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

scout premera health providing hospital prescription pharmaceutical insurance users drug medical technology